Progesterone effect on cell growth, ultrastructural aspect and estradiol receptors of normal human breast epithelial (HBE) cells in culture

Journal of Steroid Biochemistry and Molecular Biology

Volumn 73, Issue 3-4, 2000, Pages 171-181

  Malet, Catherine ^a   Spritzer, Poli ^a   Guillaumin, Delhy ^b   Kuttenn, Frédérique ^a  

^a Hop Necker 149 R de Sevres 75015 ^*  (France)

^b Ctr Inter Universitaire Microsc E   (France)

Author keywords

Estradiol; Normal breast; Progesterone; Progestins

Indexed keywords

ESTRADIOL; ESTRADIOL RECEPTOR; PROGESTERONE; PROMEGESTONE;

ARTICLE; BREAST EPITHELIUM; CELL COUNT; CELL CULTURE; CELL GROWTH; CELL ULTRASTRUCTURE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; NORMAL HUMAN; SCANNING ELECTRON MICROSCOPY;

ADOLESCENT; ADULT; BREAST; CELL DIVISION; CELLS, CULTURED; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, SCANNING; PROGESTERONE; PROGESTERONE CONGENERS; PROMEGESTONE; RECEPTORS, ESTRADIOL;

EID: 0034210858     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(00)00061-3     Document Type: Article

References (36)

1. Welsch C.W., Clemens J.A., Meites J. Effects of multiple pituitary homografts or progesterone on 7,12-dimethylbenz(a) anthracene-induced mammary tumors in rats. J. Natl. Cancer Inst. 41:1968;465-471.
2. Mac Manus M.J., Welsch C.W. The effect of estrogen, progesterone, thyroxine and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice. Cancer. 54:1984;1920-1927.
3. Horwitz K.B., Mc Guire W.L. Estrogen control of progesterone receptor in human breast cancer. Correlation with nuclear processing of estrogen receptor. J. Biol. Chem. 253:1978;2223-2228.
4. Horwitz K.B., Koseki Y., Mc Guire W.L. Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. Endocrinology. 103:1978;1742-1751.
5. Vignon F., Derocq D., Chambon M., Rochefort H. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture. J. Clin. Endocrinol. Metab. 56:1983;1124-1130.
6. Horwitz K.B., Weil L., Sedlacek S.M., d'Arville C.N. Progestin action and progesterone receptor structure in human breast cancer: a review. Rec. Prog. Horm. Res. 41:1985;249-316.
7. Vogel P.M., Georgiade N.G., Fetter B.F., Vogel S., Mc Carty K. The correlation of histologic changes in the human breast with the menstrual cycle. Am. J. Pathol. 104:1981;13-34.
8. Gompel A., Chomette G., Malet C., Spritzer P., Pavy B., Kuttenn F., Mauvais-Jarvis P. Estradiol-progestin interaction in normal human breast cells in culture. Ultrastructural studies. Breast Diseases-Senologia. 1:1985;149-156.
9. Gompel A., Malet C., Spritzer P., Lalardrie J.P., Kuttenn F., Mauvais-Jarvis P. Progestin effect on cell proliferation and 17β-hydroxysteroid dehydrogenase activity in normal human breast cells in culture. J. Clin. Endocrinol. Metab. 63:1986;1174-1180.
10. Longman S.M., Buehring G.C. Oral contraceptives and breast cancer. In vitro effect of contraceptive steroids on human mammary cell growth. Cancer. 59:1987;281-287.
11. Barrat J., de Lignieres B., Marpeau L., Larue L., Fournier S., Nahoul K., Giorgi H., Contesso G. Effect in vivo de l'administration locale de progestérone sur l'activité mitotique des galactophores humains. J. Gynecol. Obstet. Biol. Reprod. 19:1990;269-274.
12. Chang K-J., Lee T.T.Y., Linares G., Fournier S., de Lignieres B. Influences of percutaneous administration of estradiol and progesterone on epithelial cell cycle of human breast in vivo. Fertil. Steril. 63:1995;785-791.
13. Ferguson D.J.P., Anderson T.J. Morphological evaluation of cell turnover in relation to the menstrual cycle in the resting human breast. Br. J. Cancer. 44:1981;177-181.
14. Soderqvist G., Isaksson E., von Schoultz B., Carlstrom K., Tani E., Skoog L. Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am. J. Obstet. Gynecol. 176:1997;123-128.
15. Jeng M-J., Parker J., Jordan V.C. Estrogenic potential of progestins in oral contraceptives to stimulate human breast cancer cell proliferation. Cancer Res. 52:1992;6539-6546.
16. Jordan V.C., Jeng M.H., Catherino W.H., Parker C.J. The estrogenic activity of synthetic progestin used in oral contraception. Cancer. 71:1993;1501-1505.
17. Pike M.C., Henderson B.E., Krailo M.D., Duke A., Roy S. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet. 2:1983;926-929.
18. Bergkvist L., Asami M., Persson I., Hoover R., Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N. Engl. J. Med. 321:1989;293-297.
19. Prudhomme J.F., Malet C., Gompel A., Lalardrie J.P., Ochoa C., Boue A., Mauvais-Jarvis P., Kuttenn F. 17β-hydroxysteroid dehydrogenase activity in human breast epithelial cell and fibroblast cultures. Endocrinology. 114:1984;1483-1489.
20. Malet C., Gompel A., Yaneva H., Cren H., Fidji N., Mowszowicz I., Kuttenn F., Mauvais-Jarvis P. Estradiol and progesterone receptors in cultured normal human breast epithelial cells and fibroblasts: immunocytochemical studies. J. Clin. Endocrinol. Metab. 73:1991;8-17.
21. Barres D.R., Mignot J. Histomorphometry. Methods and examples of applications. Jasmin G., Proscher L. Methods and Achievements in Experimental Pathology. 11:1983;57-72 Karger, Basel.
22. Brunk C.F., Jones K.C., James T.W. Assay for nanogram quantities of DNA in cellular homogenates. Ann. Rev. Biochem. 92:1979;497-500.
23. Segaloff A. Inhibition by progesterone of radiation-estrogen-induced mammary carcinoma in the rat. Cancer Res. 33:1973;1136-1137.
24. Gottardis A., Ertuk E., Rose D.P. Effects of progesterone administration on NMU induced rat mammary carcinogenesis. Eur. J. Clin. Oncol. 19:1983;1479-1484.
25. Grubbs L.J., Farnell D.R., Hill D.L., Mac Donough K.C. Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17β-estradiol and progesterone. J. Natl. Cancer Inst. 74:1985;927-931.
26. Inoh A., Kamiya K., Kujii Y., Yokoro K. Protective effect of progesterone and tamoxifen in estrogen-induced mammary carcinogenesis in ovariectomized w/Fu rats. Jpn. J. Cancer Res. (Gann). 76:1985;699-704.
27. Welsch C.W., Mac Manus M.J., Haviland T.J., Dombroske S.E., Swim E.L., Sharpe S.J., Conley E. Hormone regulation of DNA synthesis of normal and hyperplastic human breast tissues in vitro and in vivo. Angeli A., Bradlow H.L., Dogliotti L. Endocrinology of Cystic Breast Disease. 1983;47-58 Raven Press, New York.
28. Malet C., Gompel A., Spritzer P., Kuttenn F., Mauvais-Jarvis P. Effect of estradiol and the synthetic progestin promegestone (R5020) on the proliferation of human mammary cells in culture. Ann. NY Acad. Sci. 464:1986;489-492.
29. Anderson T.J., Battersby S., King R.J.B., Mc Pherson K., Going J.J. Oral contraceptive use influences resting breast proliferation. Hum. Pathol. 20:1989;1139-1144.
30. Potten C.S., Watson R.J., Willimas G.T., Tickle S., Roberts S.A., Harris M., Howell A. The effect of age and menstrual cycle upon proliferative activity on the normal human breast. Br. J. Cancer. 258:1988;163-170.
31. Staffa J.A., Newschaffer C.J., Jones J.K., Miller V. Progestins and breast cancer: an epidemiologic review. Fertil. Steril. 57:1992;473-491.
32. Clarke C.L., Sutherland R.L. Progestin regulation of cellular proliferation: update 1993. Endocr. Rev. 1:1993;132-135.
33. Pasqualini J.R., Paris J., Sitruk-Ware R., Chetrite G., Botella J. Progestins and breast cancer. J. Steroid Biochem. Mol. Biol. 65:1998;225-235.
34. Musgrove E.A., Lee C.S.L., Sutherland R.L. Progestins both stimulate and inhibit breast cancer cell cycle progression while increasing expression of transforming growth factor α, epidermal growth factor receptor, c-fos, and c-myc genes. Mol. Cell. Biol. 11:1991;5032-5043.
35. Musgrove E.A., Swarbrick A., Lee C.S.L., Cornich A.L., Sutherland R.L. Mechanisms of cyclin-dependent kinase inactivation by progestins. Mol. Cell. Biol. 18:1998;1812-1825.
36. kip1. Mol. Endocrinol. 11:1997;1593-1607.